Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VT7208 in Healthy Participants and MS Patients

Clinical trial NCT07085507 · RECRUITING

Trial details

NCT number: NCT07085507
Sponsor: Vidya Therapeutics Inc
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2025-08-01
Primary completion: 2026-10-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.